CRISPR Therapeutics AG (CRSP)
46.03
-1.23
(-2.60%)
USD |
NASDAQ |
Nov 21, 15:01
CRISPR Therapeutics Price: 46.03 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 47.14 | 47.91 | 46.61 | 47.26 | 1.943M |
| Nov 19, 2024 | 46.97 | 47.53 | 46.56 | 46.97 | 1.527M |
| Nov 18, 2024 | 47.83 | 48.28 | 46.71 | 47.30 | 2.041M |
| Nov 15, 2024 | 47.61 | 48.44 | 46.30 | 47.25 | 3.133M |
| Nov 14, 2024 | 49.86 | 50.10 | 46.84 | 46.85 | 1.958M |
| Nov 13, 2024 | 50.90 | 52.43 | 49.40 | 49.79 | 1.863M |
| Nov 12, 2024 | 53.80 | 53.99 | 50.53 | 50.73 | 2.175M |
| Nov 11, 2024 | 53.13 | 59.07 | 53.00 | 54.86 | 3.659M |
| Nov 08, 2024 | 51.21 | 52.52 | 50.60 | 51.62 | 1.306M |
| Nov 07, 2024 | 51.40 | 53.26 | 51.14 | 51.88 | 1.598M |
| Nov 06, 2024 | 51.80 | 51.88 | 49.39 | 50.72 | 2.277M |
| Nov 05, 2024 | 49.34 | 50.42 | 47.04 | 50.36 | 2.172M |
| Nov 04, 2024 | 50.44 | 51.90 | 49.21 | 50.59 | 1.602M |
| Nov 01, 2024 | 46.96 | 50.85 | 46.91 | 50.76 | 2.263M |
| Oct 31, 2024 | 47.76 | 47.99 | 46.30 | 46.39 | 1.279M |
| Oct 30, 2024 | 48.51 | 49.87 | 47.60 | 47.93 | 1.166M |
| Oct 29, 2024 | 49.53 | 49.75 | 48.44 | 48.94 | 1.185M |
| Oct 28, 2024 | 47.99 | 50.50 | 47.75 | 49.71 | 1.707M |
| Oct 25, 2024 | 47.96 | 48.88 | 47.26 | 47.36 | 1.109M |
| Oct 24, 2024 | 46.19 | 47.98 | 45.92 | 47.95 | 1.105M |
| Oct 23, 2024 | 47.95 | 47.96 | 45.44 | 46.00 | 1.827M |
| Oct 22, 2024 | 48.26 | 48.42 | 47.82 | 48.04 | 834047.0 |
| Oct 21, 2024 | 48.59 | 48.94 | 48.20 | 48.51 | 788699.0 |
| Oct 18, 2024 | 48.55 | 49.24 | 48.40 | 48.92 | 782357.0 |
| Oct 17, 2024 | 48.91 | 49.28 | 48.25 | 48.29 | 1.151M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
33.68
Minimum
Mar 16 2020
210.04
Maximum
Jan 14 2021
74.89
Average
63.28
Median
Jun 28 2022
Price Benchmarks
| Vertex Pharmaceuticals Inc | 449.98 |
| AC Immune SA | 3.24 |
| Addex Therapeutics Ltd | 7.75 |
| NLS Pharmaceutics Ltd | 3.31 |
| Molecular Partners AG | 5.34 |
Price Related Metrics
| Price to Book Value | 2.025 |
| Earnings Yield | -6.08% |
| Market Cap | 3.929B |